As hospitals adapt to a landscape marked by staffing shortages, financial pressure and escalating safety concerns, security can no longer operate as an afterthought or a cost center. It must be a strategic enabler that protects the workforce, which in turn protects everyone else. The post Rethinking Security Among the Healthcare Workforce Crisis appeared first…
Nextech CEO Rusty Frantz details the launch of Cora Scribe with an early focus on ophthalmology
[Sponsored] A recent webinar sponsored by Overjet offered insights from Affinity Dental Management executives on how AI-driven clinical intelligence software can transform DSOs. The post How One Leading DSO Used Analytics to Drive a 26% Increase in Crown Treatment Planning Rates appeared first on MedCity News.
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Kaitlin Cooke of Cartersville, Georgia, was contemplating suicide when she started calling a statewide mental health crisis line in 2018. She said she would sneak outside and call the hotline…
Investors at Breyer Capital think 2026 could mark a turning point in digital health, as logistics become as important as scientific innovation. They highlighted three key trends shaping the market: shifting biotech constraints from biology to delivery, bottom-up product adoption by clinicians, and a wave of consolidation among AI startups. The post Which Digital Health…
CMS officials have proposed a payment increase of less than 0.1 percent for 2027. Investors slammed shares of prominent insurance companies in response.
At the recent J.P. Morgan conference, CEO Cary Grace said clients are, after the turmoil of the COVID era, back to focusing more on combining efficient spending with finding and keeping talent.
Preliminary Phase 2 data show Roche’s CT-388 led to a 22.5% placebo-adjusted weight loss measured at 48 weeks. Based on these results, the pharmaceutical company plans to advance the GLP-1 and GIP agonist to a Phase 3 clinical trial in obesity. The post Roche Obesity Drug’s Phase 2 Results Are Competitive, But True Test May…
This is Wisp’s first acquisition, for which the terms of the deal were not disclosed. It allows the company to expand into providing in-person care to complement its virtual support. The post Wisp Acquires Sexual Health Platform TBD Health appeared first on MedCity News.
Lumeris says ‘Tom’ platform to enable tracking, performance management, and scalable best-next-action workflows embedded in clinical operations